Triad Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$214K Sell
436
-54
-11% -$29.3K 0.02% 458
2025
Q4
$284K Buy
+490
New +$277K 0.03% 396
2024
Q3
Sell
-78
Closed -$43.1K 828
2024
Q2
$43.1K Buy
+78
New +$44.7K 0.02% 251

Other funds holding TMO

Triad Wealth Partners's TMO Position: Q1 2026 in Review

Triad Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q1 2026, selling an estimated $29.3K and leaving 436 shares worth $214K. The position accounts for 0.02% of the portfolio, ranked #458.

Triad Wealth Partners first reported a position in TMO in Q2 2024 and has held it in 3 quarters since. The position peaked at $284K in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Triad Wealth Partners held 436 shares of Thermo Fisher Scientific worth $214K as of Q1 2026.
  • Triad Wealth Partners sold 54 Thermo Fisher Scientific shares in Q1 2026, an estimated $29.3K.
  • Thermo Fisher Scientific made up 0.02% of Triad Wealth Partners's portfolio in Q1 2026, its #458 holding.
  • Triad Wealth Partners first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 3 quarters since.
  • Triad Wealth Partners's Thermo Fisher Scientific position peaked at $284K in Q4 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Triad Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.